Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation

European Heart Journal

Volumn 22, Issue 11, 2001, Pages 964-971

  Ciliberto, Guglielma R ^a,b   Ruffini, L ^a   Mangiavacchi, M ^a   Parolini, M ^a   Sara, R ^a   Massa, D ^a   De Maria, R ^a   Gronda, E ^a   Vitali, E ^a   Parodi, O ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b NONE   (Italy)

Author keywords

Echocardiography; Heart transplantation; Perfusion imaging; Prognosis

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC99M; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FEMALE; GRAFT OCCLUSION; GRAFT REJECTION; HEART LEFT VENTRICLE WALL MOTION; HEART PERFUSION; HEART SCINTISCANNING; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK; SURVIVAL ANALYSIS; TECHNETIUM TC 99M SESTAMIBI; TIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0034936771     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2422     Document Type: Article

References (29)

1. The registry of the international society for heart and lung transplantation ninth official report - 1992
2. Hypercholesterolemia in long-term survivors of heart transplantation: An early marker of accelerated coronary artery disease
3. Accelerated coronary vascular disease in heart transplant patients: Coronary arteriographic findings
4. Coronary artery disease after heart transplantation: Timing of coronarry arteriography
5. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant
6. Exercise echocardiography in heart transplant recipients: A comparison with angiography and intracoronary ultrasound
7. Exercise echocardiography, angiography, and intracoronary ultrasound after cardiac transplantation
8. Use of exercise electrocardiography, technetium-99m-MIBI perfusion tomography, and two-dimensional echocardiography for coronary disease surveillance in a low-prevalence population of heart transplant recipients
9. Coronary artery disease after heart transplantation: Non-invasive evaluation with exercise thallium scintigraphy
10. High-dose dipyridamole echocardiography test in coronary artery disease after heart transplantation
11. Dobutamine stress echocardiography in orthotopic heart transplant recipients
12. Role of dobutamine stress echocardiography in heart transplant recipients
13. Role of dobutamine stress echocardiography for diagnosis of cardiac allograft vasculopathy
14. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: A comparison of thallium-201 and technetium 99m Sestamibi
15. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group
16. Recommendations for quantification of the left ventricle by two-dimensional echocardiography
17. Accuracy and safety of Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: A multicenter study
18. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of 'angiographically silent' intimal thickening
19. Presence of severe intimal thickening by intravascular ultrasound predicts cardiac events in cardiac allograft vasculopathy
20. Non-invasive assessment of transplant-associated arteriosclerosis
21. The prognostic significance of non-invasive cardiac tests in heart transplant recipients
22. Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation
23. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography
24. Comparison of dobutamine echocardiography and Thallium SPECT with coronary angiography to predict cardiac events in asymptomatic heart transplant recipients
25. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy. Comparison with coronary angiography and intravascular ultrasound
26. Analysis of inter-institutional observer agreement in interpretation of dobutamine stress echocardiograms
27. Dipyridamole vasodilator response after human orthotopic heart transplantation: Quantification by oxygen-15-labeled water and positron emission tomography
28. Persistence of coronary vasodilator responsivity after cardiac transplantation
29. Intèret de la tomoscintigraphie myocardique double isotope dans la détection de la maladie coronaire du greffon chez 96 transplantés cardiaques